89Bio Investor Relations Material
Latest events
Study Result
89Bio
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from 89Bio Inc
Access all reports
89Bio Inc is a clinical-stage biopharmaceutical company focused to the development and commercialization of therapies aimed at treating liver and cardio-metabolic diseases. The company is building a pipeline that includes biologic and small molecule treatments, focusing on addressing unmet medical needs in these therapeutic areas. The company is headquartered in San Francisco, California, and its shares are listed on the NASDAQ under the symbol ETNB.
Key slides for 89Bio Inc
Corporate Presentation
89Bio Inc
Corporate Presentation
89Bio Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States